MSB 3.21% $1.13 mesoblast limited

Ann: Update on FDA Meeting for Remestemcel-L in Paediatric GvHD, page-55

  1. 7,144 Posts.
    lightbulb Created with Sketch. 1324
    Dream bigger. I'm hoping the next announcement is a deal/partnership/cash. $$$$ has arrived previously with much less. This is all but, but.

    It looks like SI has held out for a bigger payday. Maybe. Well, it's what I secretly hope anyway.

    Let's start a HC fact that Novartis are tight-arses.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.